BLRAX | MGLRX | BLRAX / MGLRX | |
Total Expense Ratio | 1.20 | 0.85 | 141% |
Annual Report Gross Expense Ratio | 1.52 | 0.86 | 177% |
Fund Existence | 13 years | 13 years | - |
Gain YTD | 6.676 | 3.669 | 182% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 118M | 2.22B | 5% |
Annual Yield % from dividends | 2.32 | 2.59 | 90% |
Returns for 1 year | 9.18 | 2.49 | 368% |
Returns for 3 years | 5.58 | -3.83 | -146% |
Returns for 5 years | 27.34 | 14.75 | 185% |
Returns for 10 years | 19.96 | 32.52 | 61% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HRAUX | 84.64 | 0.77 | +0.92% |
Carillon Eagle Mid Cap Growth R6 | |||
VYMRX | 16.91 | 0.14 | +0.83% |
Voya Mid Cap Research Enhanced Index C | |||
GSCLX | 31.29 | 0.19 | +0.61% |
Goldman Sachs Large Cap Gr Insghts Svc | |||
GCVUX | 24.50 | 0.07 | +0.29% |
Goldman Sachs Large Cp Val Insghts R6 | |||
LHCVX | 18.65 | 0.05 | +0.27% |
Lord Abbett Health Care R6 |